Skip to main content
Veterinary Medicines

Laxatract 667 mg/ml oral solution

Authorised
  • LACTULOSE, LIQUID

Product identification

Medicine name:
Laxatract 667 mg/ml oral solution
Active substance:
  • LACTULOSE, LIQUID
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • LACTULOSE, LIQUID
    667.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA06AD11
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • HDPE bottle closed with a (LDPE) syringe inlay and a (HDPE) cap. Cardboard box of 1 bottle of 50 ml with a 5ml oral syringe.
  • HDPE bottle closed with a (LDPE) syringe inlay and a (HDPE) cap. Cardboard box of 1 bottle of 125 ml with a 5ml oral syringe.
  • HDPE bottle closed with a (LDPE) syringe inlay and a cap (PP). Cardboard box of 1 bottle of 325 ml with a 10ml oral syringe.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Feramed B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • 50406/4000
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0241/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."